Clinical Cancer Research · 2004 · 99 citations · 18 references
Life SciencesGeneticsMolecular GeneticsCancer GeneticsHuman GeneticsMedical GeneticsGastrointestinal NeoplasmsGastrointestinal Stromal TumorsGenetic DisordersGermline Cancer SusceptibilityHereditary Cancer SyndromesHereditary Gastrointestinal Cancer SyndromesAutosomal Dominant InheritanceFamilial Gastrointestinal Stromal TumorsGermline MutationsGermline PredispositionGrowth Factor Receptor ActivationMutationSomatic MutationsUrticaria Pigmentosa
PURPOSE: Somatic mutations that result in the activation of the growth factor receptor KIT are commonly found in gastrointestinal stromal tumors (GISTs). Six families have been reported in which a germ-line mutation in KIT is associated with an autosomal dominant predisposition to the development of GISTs. Hyperpigmentation, urticaria pigmentosa, and dysphagia have been described in some, but not all, families. Preliminary correlations between the site of mutation and the clinical phenotype have been proposed, but the strength of these associations is not defined. DESIGN: A large kindred with multiple GISTs, hyperpigmentation, and dysphagia was identified after the index case presented with multiple GISTs. A germ-line mutation in KIT (W557R) was identified in an affected cousin, after which a large family meeting was held and testing offered. Clinical data were obtained by interview and, whenever possible, medical record documentation. RESULTS: To date, 19 individuals have been tested, and the mutation has been shown to cosegregate with the syndrome. The phenotypic expression, however, is variable. GISTs, often presenting as upper gastrointestinal bleeding, and hyperpigmentation are common, but not diagnosed in all documented or obligate carriers. Dysphagia is a less prevalent complaint. The diagnosis of GISTs appears to be made at a younger age in more recent generations. Metastatic disease is uncommon. CONCLUSIONS: A germ-line mutation in KIT resulting in an amino acid substitution in the juxtamembrane region is associated with a syndrome of GIST, hyperpigmentation, and dysphagia, although the prominence of each component varies.
18
Gain-of-Function Mutations of c- <i>kit</i> in Human Gastrointestinal Stromal Tumors
Seiichi Hirota, Koji Isozaki, Y Moriyama et al. · Science · 1998 · 4.5K citations
KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.
Brian P. Rubin, Samuel Singer, C. Tsao et al. · PubMed · 2001 · 969 citations
KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal Tumors
Marcia L. Lux, Brian P. Rubin, Tara L. Biase et al. · American Journal Of Pathology · 2000 · 647 citations · Full text
Clinical management of gastrointestinal stromal tumors: Before and after STI-571
Ronald P. DeMatteo, Michael C. Heinrich, Wael El‐Rifai et al. · Human Pathology · 2002 · 637 citations